HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Espinosa-Heidmann, D. G. Articles by Cousins, S. W. Search for Related Content PubMed PubMed Citation Articles by Espinosa-Heidmann, D. G. Articles by Cousins, S. W.

Age as an Independent Risk Factor for Severity of Experimental Choroidal Neovascularization

¹ From the Bascom Palmer Eye Institute, Department of Ophthalmology, The University of Miami School of Medicine, Miami, Florida; and the ² National Eye Institute, National Institutes of Health, Bethesda, Maryland.

PURPOSE. For many vascular diseases, aging appears to be an independent risk factor for severity of vascular complications, and blood vessels of aged individuals often demonstrate exaggerated repair responses to injury. This study was undertaken to determine the influence of aging on the severity of neovascularization in a mouse model of laser-induced choroidal neovascularization (CNV).

METHODS. CNV was induced in young (2-month-old) and aged (16-month-old) C57BL/6 mice by making four separate choroidal burns in each eye with a diode red laser (650 nm). At 1, 2, and 4 weeks, the left eyes were removed for histopathology, and the right eyes were removed for flatmount analysis of CNV surface area, vascularity, and cellularity.

RESULTS. Aged mice demonstrated a much larger area of CNV than did young mice (3.81 ± 1.28 vs. 1.36 ± 0.99 disc areas, P < 0.001) at 2 weeks, when the lesions showed maximum growth. Aged mice also demonstrated higher ratios for vascularity and cellularity of the CNV (1.34 ± 0.06 vs. 1.03 ± 0.11, P < 0.0001 and 4.06 ± 1.19 vs. 1.91 ± 0.81, P < 0.002 at 2 weeks, respectively). Histopathology revealed that CNV in older eyes was larger, thicker, and more cellular than in young eyes.

CONCLUSIONS. In mice, age is associated with more severe CNV, defined as larger surface area, greater vascularity, and greater cellularity. Age–related systemic susceptibility factors, independent of local changes in the retina, may contribute to the greater severity of CNV in older than in younger individuals.

This article has been cited by other articles:

				A. G. Marneros, H. She, H. Zambarakji, H. Hashizume, E. J. Connolly, I. Kim, E. S. Gragoudas, J. W. Miller, and B. R. Olsen Endogenous endostatin inhibits choroidal neovascularization FASEB J, December 1, 2007; 21(14): 3809 - 3818. [Abstract] [Full Text] [PDF]

				M. E. Marin-Castano, G. E. Striker, O. Alcazar, P. Catanuto, D. G. Espinosa-Heidmann, and S. W. Cousins Repetitive Nonlethal Oxidant Injury to Retinal Pigment Epithelium Decreased Extracellular Matrix Turnover In Vitro and Induced Sub-RPE Deposits In Vivo. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4098 - 4112. [Abstract] [Full Text] [PDF]

				B. Sung, S. Park, B. P. Yu, and H. Y. Chung Modulation of PPAR in Aging, Inflammation, and Calorie Restriction J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2004; 59(10): B997 - B1006. [Abstract] [Full Text] [PDF]

				W.-Y. Shen, S. Y. Lee, I. Yeo, C.-M. Lai, R. Mathur, D. Tan, I. J. Constable, and P. E. Rakoczy Predilection of the Macular Region to High Incidence of Choroidal Neovascularization After Intense Laser Photocoagulation in the Monkey Arch Ophthalmol, March 1, 2004; 122(3): 353 - 360. [Abstract] [Full Text] [PDF]

				I. J. Suner, D. G. Espinosa-Heidmann, M. E. Marin-Castano, E. P. Hernandez, S. Pereira-Simon, and S. W. Cousins Nicotine Increases Size and Severity of Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 311 - 317. [Abstract] [Full Text] [PDF]

				D. G. Espinosa-Heidmann, A. Caicedo, E. P. Hernandez, K. G. Csaky, and S. W. Cousins Bone Marrow-Derived Progenitor Cells Contribute to Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4914 - 4919. [Abstract] [Full Text] [PDF]

				E. Sakurai, A. Anand, B. K. Ambati, N. van Rooijen, and J. Ambati Macrophage Depletion Inhibits Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3578 - 3585. [Abstract] [Full Text] [PDF]

				D. G. Espinosa-Heidmann, I. J. Suner, E. P. Hernandez, D. Monroy, K. G. Csaky, and S. W. Cousins Macrophage Depletion Diminishes Lesion Size and Severity in Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3586 - 3592. [Abstract] [Full Text] [PDF]

				E. Sakurai, H. Taguchi, A. Anand, B. K. Ambati, E. S. Gragoudas, J. W. Miller, A. P. Adamis, and J. Ambati Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2743 - 2749. [Abstract] [Full Text] [PDF]

				V. Lambert, C. Munaut, P. Carmeliet, R. D. Gerard, P. J. Declerck, A. Gils, C. Claes, J.-M. Foidart, A. Noel, and J.-M. Rakic Dose-Dependent Modulation of Choroidal Neovascularization by Plasminogen Activator Inhibitor Type I: Implications for Clinical Trials Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2791 - 2797. [Abstract] [Full Text] [PDF]